Clinical Trials Browser

Phase 1/2 × elacestrant × 30 days × Clear all

Brain Diseases, Brain Neoplasms, Breast Diseases, Breast Neoplasms, Central Nervous System Diseases, Neoplasms, Neoplasms by Site, Central Nervous System Neoplasms

NCT07612215 2026-05-28

Elacestrant in Advanced Triple Positive Breast Cancer

Phase 1/2 Recruiting

50 enrolled

Breast

Breast Neoplasms

Clinical Trials

ELECTRA

Elacestrant in Advanced Triple Positive Breast Cancer